Pharma IQ Members

IQPC User Agreement

Welcome to the User Agreement for IQPC and its affiliates. This agreement describes the terms on which you may access and use our services. In order to become an IQPC user, you must read and accept all of the terms and conditions of this agreement and the Privacy Policy. In the event of any inconsistency between the IQPC Privacy Policy and this User Agreement, the User Agreement shall control. Nothing in this Agreement shall be deemed to confer any third-party rights or benefits. If you do not agree to be bound by the terms of this Agreement, you may not use nor access our services. 

We reserve the right to modify this Agreement at any time, and without prior notice, by posting amended terms on this Web site. Your continued use of the IQPC service indicates your acceptance of the amended User Agreement. 

Description of Service

IQPC is an online service offered to enable professionals to find and connect with other professionals more effectively (the "IQPC Service"). Whether looking for a job, a lead for that next deal or an industry expert, IQPC users can make contact with thousands of professionals who are users of the IQPC Service. 

Membership Eligibility

The IQPC Service is not available to minors under the age of 18 or to any users suspended or removed from the system by IQPC for any reason. Users may not have more than one active account. Additionally, users are prohibited from selling, trading or otherwise transferring your IQPC account to another party. If you do not qualify, you may not use the IQPC Service. 

Use of Service

Your use of the IQPC Service is governed by this User Agreement. IQPC may refuse service without prior notice to any user for any or no reason. You are responsible for maintaining the confidentiality of your password and account and are fully responsible for all activities that occur under your password or account with or without your knowledge. If you knowingly provide your login and password information to another person, your account privileges may be suspended temporarily or terminated. You agree to immediately notify IQPC of any unauthorized use of your password or account or any other breach of security. IQPC cannot and will not be liable for any loss or damage arising from your failure to comply with this section. 

Termination

You agree that IQPC may, with or without cause, immediately terminate your IQPC account and access to the IQPC Service without prior notice. Without limiting the foregoing, the following will lead to a termination by IQPC of a user's use of the IQPC Service: a) breaches or violations of this User Agreement or other incorporated agreements or guidelines, b) requests by law enforcement or other government agencies, c) a request by you (self-initiated account deletions), d) unexpected technical issues or problems and e) extended periods of inactivity. Termination of your IQPC account includes removal of access to all offerings within the IQPC Service and may also bar you from further use of the IQPC Service. Furthermore, you agree that all terminations shall be made in IQPC's sole discretion and that IQPC shall not be liable to you nor 

User Conduct

You understand and agree not to use IQPC to:

• Post content or initiate communications that are unlawful, libelous, abusive, obscene, discriminatory or otherwise objectionable.

• Use the IQPC Service for any illegal purpose, including but not limited to conspiring to violate laws.

• Falsely state, impersonate or otherwise misrepresent your identity, including but not limited to the use of a pseudonym, or misrepresenting your current or previous positions and qualifications, or your affiliations with a person or entity, past or present.

• Upload, post, e-mail, transmit or otherwise make available any content or initiate communications that include information that you do not have the right to disclose or make available under any law or under contractual or fiduciary relationships (such as insider information, or proprietary and confidential information learned or disclosed as part of employment relationships or under nondisclosure agreements).

• Upload, post, e-mail, transmit or otherwise make available any content or initiate communication that infringes upon patents, trademarks, trade secrets, copyrights or other proprietary rights.

• Upload, post, e-mail, transmit or otherwise make available any unsolicited or unauthorized advertising, promotional materials, "junk mail," "spam," "chain letters," "pyramid schemes" or any other form of solicitation. This prohibition includes but is not limited to: a) using IQPC invitations to send messages to people who don't know you or who are unlikely to recognize you as a known contact; b) using IQPC to connect to people who don't know you and then sending unsolicited promotional messages to those direct connections without their permission and c) sending messages to distribution lists, newsgroup aliases, or group aliases.

• Upload, post, e-mail, transmit or otherwise make available any material that contains software viruses or any other computer code, files or programs designed to interrupt, destroy or limit the functionality of any computer software or hardware or telecommunications equipment.

• Stalk or harass anyone.

• Forge headers or otherwise manipulate identifiers in order to disguise the origin of any communication transmitted through the IQPC Service.

• Post content in fields that aren't intended for that content. Example: Putting an address in a name or title field.

• Interfere with or disrupt the IQPC Service or servers or networks connected to the IQPC Service, or disobey any requirements, procedures, policies or regulations of networks connected to the IQPC Service.

International Use 

Recognizing the global nature of the Internet, you agree to comply with all applicable local rules including but not limited to rules regarding online conduct and acceptable content. Specifically, you agree to comply with all applicable laws regarding the transmission of technical data exported from the United States or the country in which you reside. 

Information Provided on this Web Site

In the course of using the IQPC Service, users may provide information about themselves that may be visible to certain other users (see our Privacy Policy to learn more about information collected on this Web site). You understand that by posting materials on the IQPC Web site or otherwise providing materials to IQPC, you are granting to IQPC and its affiliates a royalty-free, perpetual, irrevocable license to use this information in the course of offering the IQPC Service. Furthermore, you understand that IQPC retains the right to reformat, excerpt or translate any materials submitted by you. You understand that all information publicly posted or privately transmitted through the IQPC Service is the sole responsibility of the person from which such content originated and that IQPC will not be liable for any errors or omissions in any content. You understand that IQPC cannot guarantee the identity of any other users with whom you may interact in the course of using the IQPC Service. Additionally, we cannot guarantee the authenticity of any data that users may provide about themselves or relationships they may describe. 

Access to Service

Use of manual or automated software, devices or other processes to "crawl" or "spider" any Web pages contained in the IQPC Web site is strictly prohibited. You agree not to monitor or copy, or allow others to monitor or copy, our Web pages or the content included herein. You also agree not to "frame" or otherwise simulate the appearance or function of this Website. Furthermore, you agree not to take any action that interferes with the proper working of or places an unreasonable load on our infrastructure, including but not limited to unsolicited communications, attempts to gain unauthorized access or transmission or activation of computer viruses. 

IQPC Communications

In the course of providing you services, IQPC may need to communicate with you via e-mail (see our Privacy Policy to learn more about communications). You agree to receive e-mails that are specific to your account and necessary for the normal functioning of the IQPC Service, including a series of up to five welcome e-mails, which help inform new users about various features of the IQPC Service. You also agree to have your name and/or e-mail address listed in the header of certain communications that you initiate through the IQPC Service. 

Monitoring and Enforcement 

While we have the right to monitor activity and content associated with the IQPC Service, we are not obligated to do so. And since we do not, and may not have the ability to, control or actively monitor content we don't guarantee its accuracy, integrity or quality. Because community standards vary and individuals sometimes choose not to comply with our policies and practices, in the process of using our Web site, you may be exposed to content that you find offensive or objectionable. You can contact our Customer Service Department to let us know of content that you find objectionable. We may investigate the complaints and violations of our policies that come to our attention and may take any action that we believe is appropriate, including, but not limited to issuing warnings, removing the content or terminating accounts and/or subscriptions. However, because situations and interpretations vary, we also reserve the right not to take any action. Under no circumstances will we be liable in any way for any content, including, but not limited to, any errors or omissions in any content, or any loss or damage of any kind incurred as a result of the use of, access to, or denial of access to any content on the Web site.

Fees

Signing up for a basic IQPC account is free. Certain other services are provided for free only to beta users. IQPC reserves the right to charge for the IQPC Service or any portion thereof, modify the pricing of, add to, or discontinue the IQPC Service or any portion thereof without prior notice. 

Indemnification

By accepting this User Agreement, you agree to indemnify and otherwise hold harmless IQPC and its affiliates, its officers, employees, agents, subsidiaries, affiliates and other partners from any direct, indirect, incidental, special, consequential or exemplary damages resulting from: i) your use of the IQPC Service, ii) unauthorized access to or alteration of your communications with or through the IQPC Service or iii) any other matter relating to the IQPC Service. Any business transactions which may arise between users from their use of IQPC are the sole responsibility of the users involved. Without limitation of the terms and conditions set forth in our Privacy Policy, you understand and agree that IQPC may disclose personally identifiable information if required to do so by law or in the good faith belief that such disclosure is reasonably necessary to comply with legal process, enforce this User Agreement, or protect the rights, property or safety of IQPC, its users and the public. 

disclaimer of warranties

YOU UNDERSTAND AND AGREE THAT THE IQPC SERVICE IS PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS AND THAT IQPC DOES NOT ASSUME ANY RESPONSIBILITY FOR PROMPT OR PROPER DELIVERY OR RETENTION OF ANY USER INFORMATION OR COMMUNICATIONS BETWEEN USERS. IQPC ASSUMES NO RESPONSIBILITY FOR THE ACCURACY OR EXISTENCE OF ANY COMMUNICATIONS BETWEEN USERS. IQPC EXPRESSLY DISCLAIMS ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT. 

IQPC MAKES NO WARRANTY THAT: i) THE IQPC SERVICE WILL MEET YOUR REQUIREMENTS, ii) THE IQPC SERVICE WILL BE UNINTERRUPTED, TIMELY, SECURE OR ERROR-FREE, iii) THE RESULTS THAT MAY BE OBTAINED FROM USE OF THE IQPC SERVICE WILL BE ACCURATE OR RELIABLE, iv) THE QUALITY OF ANY PRODUCTS, SERVICES, INFORMATION, OR OTHER MATERIAL PURCHASED OR OBTAINED BY YOU THROUGH THE IQPC SERVICE WILL MEET YOUR EXPECTATIONS AND V) ANY ERRORS IN THE SOFTWARE WILL BE CORRECTED. 

ANY MATERIAL DOWNLOADED OR OTHERWISE OBTAINED THROUGH THE USE OF THE IQPC SERVICE IS DONE AT YOUR OWN DISCRETION AND RISK AND THAT YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY SUCH MATERIAL. 

NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM IQPC OR THROUGH OR FROM THE IQPC SERVICE SHALL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS USER AGREEMENT. 

SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF CERTAIN WARRANTIES OR THE LIMITATION OR EXCLUSION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES. ACCORDINGLY, SOME OF THE ABOVE LIMITATIONS MAY NOT APPLY TO YOU. 

Entire Agreement

The User Agreement constitutes the entire agreement between you and IQPC and governs your use of the IQPC Service, superseding any prior agreements between you and IQPC. 

Limitation of Liability

YOU EXPRESSLY UNDERSTAND AND AGREE THAT IQPC SHALL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA OR OTHER INTANGIBLE LOSSES (EVEN IF IQPC HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES). SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF THE LIMITATION OR EXCLUSION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES. ACCORDINGLY, SOME OF THE ABOVE LIMITATIONS MAY NOT APPLY TO YOU. IN NO EVENT WILL IQPC'S TOTAL CUMULATIVE DAMAGES EXCEED U.S. $100. 

General Information

IQPC, the IQPC logo, and other IQPC logos and names are trademarks of IQPC and its affiliates. You agree not to display or use these trademarks in any manner without IQPC's prior, written permission. The section titles of this User Agreement are displayed for convenience only and have no legal effect.

64 results
of 3

Taking a New Approach: Pfizer's Graham Martin on the Benefits & Lessons Learnt from Developing a Geographical Zoning Approach

Wed, 10/23/2013
Ahead of the 13th Annual Cool Chain & Controlled Room Temperature Logistics Europe in January, Cold Chain IQ caught up with industry keynote speaker Graham Martin, Supply Chain Excellence Senior Manager, Pfizer Havant UK - supporting Pfizer Global Logistics, to find out the benefits and key principles of developing a geographical zoning...
Listen now


USDA’s Food Safety and Inspection Service Dr. Regina Tan on Managing and Reducing the Risk of Food Recalls

Sun, 09/29/2013
In this exclusive Cold Chain IQ interview, Dr. Regina L. Tan Director, Recall Management and Technical Analysis Staff , Office of Field Operations, Food Safety and Inspection Service (FSIS), United States Department of Agriculture (USDA), speaks to Andrea Charles from Cold Chain IQ about the key logistical challenges for an effective recall and...
Listen now


Robert Knetl on Protecting Proprietary Information & Ensuring Supply Chain Integrity

Tue, 07/30/2013
In this interview Robert Knetl, Director of Washington Operations at Georgia Tech Research Institute, speaks to Andrea Charles from Cold Chain IQ, about the challenges of managing silos and protecting proprietary information in the supply chain whilst trying to ensure supply chain integrity. Knetl also shares his insights on the cloud and his...
Listen now


Cold Chain a Global Entity - Shire's Mark Lovell on Optimising Shipments

Mon, 06/17/2013
In this interview Mark Lovell, Senior Cold Chain Specialist from Shire talks to Andrea Charles from Cold Chain IQ, about the increasing focus by the regulators on controlled room temperature (CRT) / ambient products, investment levels in temperature controlled distribution and recent trends. Lovell also imparts his top tips for optimising...
Listen now


The 4 Pillars of Control Room Temperature & Cold Chain Shipping

Tue, 06/04/2013
Ocean container freight is considered a less expensive transportation mode for goods, and can be a good option for lower-cost, more stable solid-dose products. In this exclusive interview Terence Dunleavy, Director, Global Transportation Operations, Hospira, speaks to Andrea Charles from Cold Chain IQ, about the migration from air to ocean,...
Listen now


Meeting the Challenges of Today's Cold Chain Logistics

Thu, 05/23/2013
Meeting the Challenges of Today's Cold Chain LogisticsThe transportation and logistics of bio-pharmaceutical products is a very complex process. In this Cold Chain interview Tom Grubb, Manager, Cold Chain Strategy, American Airlines Cargo, highlights current trends he is witnessing in the logistics and storage of temperature-sensitive life science...
Listen now


Regulatory Challenges: Transporting and Distributing Clinical Trial Materials and Biologics

Wed, 05/01/2013
Mary Foster is the chair of the USP's committee on Packaging, Storage and Distribution. In this podcast, she discusses the regulatory challenges of transporting and distributing clinical trial materials and biologics, and also her position with Athena Pharma Solutions. Have Your SayRate this feature and give us your feedback in the comments...
Listen now


Best Practices for Transporting Biologics

Tue, 04/30/2013
Gary Hutchinson, President of Modality Solutions, spent over decade directing cold chain logistics at Amgen and Edwards Lifesciences. In this podcast, he discusses best practices for transporting biologics and what emerging technologies will impact the supply chain. Have Your SayRate this feature and give us your feedback in the comments section...
Listen now


Have You Put the New EU GDP Guidelines in Your 2013 Budget?

Sun, 04/07/2013
Jacques Dysli, Partner at Supply Chain Operations SA, talks to Andrea Charles from Cold Chain IQ, about current tactics for achieving supply chain integrity and data visibility for risk mitigation, the hottest topics in the temperature controlled supply and how the new GDP guidelines are impacting controlled rooom temperature( CRT) logistics and...
Listen now


New GDP Guidelines will be a Real Challenge for Wholesalers

Tue, 03/26/2013
The European Commission issued final revised Good Distribution Practices (GDP) guidelines on 8 March 2013. In this exclusive interview Thomas Brýckner, Head of Pharmaceutical Affairs/ Medical Devices/ CAM of The German Pharmaceutical Industry Assosciation (BPI), speaks to Andrea Charles from Cold Chain IQ, about how revised guidelines on good...
Listen now


Crescendo Bioscience's Meserve Platt on Reverse Logistics Management

Tue, 03/19/2013
In this interview Meserve Platt, Associate Director Materials / Facilities, Crescendo Bioscience, Inc., speaks to Andrea Charles from Cold Chain IQ, about finding the right partners to improve service levels, managing reverse logistics and 3rd party partnerships and collaborations. Platt also shares his future outlook on the diagnostic landscape...
Listen now


Want Better Biologistics? Remove Your Organisational Silos

Sun, 03/10/2013
What is the weakest link in cold chain supply? Will cloud computing revolutionise the biopharmaceutical supply chain? In this interview Carlos Castro Global Transportation and Logistics, Bayer Healthcare and Andrea Charles from Cold Chain IQ, discuss the importance of quality biologistics, key regulatory and operation considerations for cold chain...
Listen now


DGAC Chairman Jay Johnson on Regulatory Compliance in Biologistics

Thu, 02/28/2013
In this exclusive interview Jay Johnson, DGSA, Regulatory Compliance from Inmark, and Chairman of the Dangerous Goods Advisory Council (DGAC) Board of Directors, speaks to Andrea Charles from Cold Chain IQ, about new initiatives at the DGAC, the key challenges of shipping dangerous biologics and shares his top tip for successful secure and...
Listen now


Ministry of Health's Taha Yayci on Turkey's Pharmaceutical Tracking System: Cost, Control and Counterfeiting - Part One

Wed, 12/19/2012
"It's not impossible". Taha Yayci, M.S. Republic of Turkey Ministry of Health. The Turkish "Pharmaceutical Track and Trace System" (abbreviated as ITS) defines the infrastructure constructed to track and trace all units belonging to each pharmaceutical product in Turkey. ITS is the application of the well-known "Track & Trace" structure...
Listen now


CAPDM's Allan Reynolds: Expect Greater Scrutiny By Health Canada on the Supply Chain

Tue, 12/18/2012
In 2013 Health Canada begins its 3 year cycle of updating Guidlines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069). Allan Reynolds, Vice President, Industry and Member Relations for theCanadian Association for Pharmacy Distribution Management (CAPDM), speaks to Andrea Charles from Cold Chain IQ, about the...
Listen now


AIG: 3 Top Tips for Improving Supply Chain Security & How to Prevent Fraudulent Pick Up

Tue, 12/18/2012
In recent years we have witnessed an increase in fraudulent pick up as thieves have become more sophiscated. In this Cold Chain IQ interview , Alan F. Spear, Director, Cargo Security Loss Control, US/Canada at AIG & Immediate Past Chair, TAPA Americas and Andrea Charles, Editor for Cold Chain IQ, discuss the latest trends in supply chain...
Listen now


Johannes Schoen on the EU Falsified Medicines Directive, Weak Links & Top Tips for Improving Supply Chain Visibility

Thu, 11/08/2012
In this interview Johannes Schoen, Senior Manager, Anti-Counterfeiting at Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about the key uncertainties surrounding pharmaceutical serialisation and the impact recent serialisation initiatives will have on the pharma industry. Schoen also shares his thoughts on the implications the...
Listen now


Common Misconceptions in Temp Controlled Pharma Supply

Wed, 09/19/2012
In Part 1 of this podcast interview, Arminda O. Montero, Global Distribution QA Program Manager Abbott, and Andrea Charles Editor Cold Chain IQ, discuss establishing a global qualification master plan, risk management, quality processes and common misconceptions in the temperature controlled pharmaceutical supply chain. Have Your SayRate this...
Listen now


Are You Ready for Pharmaceutical Distribution in Central & Eastern Europe?

Sun, 08/19/2012
Central and Eastern Europe is a rapidly emerging market for pharmaceutical distribution with huge growth occurring across the region. In this podcast Jan Slezak, Logistics & Supply Chain Manager at NEOMED, and Andrea Charles from Cold Chain IQ, discuss the biggest challenges with distribution in the Central & Eastern Europe (CEE) region...
Listen now


The Importance of the ‘Last Mile’ in the Overall Supply Chain

Wed, 07/11/2012
Frank Binder, Director of International Logistics and Supply Chain at Celgene, joins Cold Chain IQ to discuss how pharmaceutical distribution can add more value to business. Firstly, he discusses the importance of the ‘last mile’ to the overall supply chain. He then reflects on the change across the industry at the moment when it comes to...
Listen now


Genzyme's Chris Wallace on Temperature Controlled Distribution to Small Patient Pools and Change Management in the End-to-End Supply Chain

Tue, 06/26/2012
"A problem shared is a problem minimised." In this podcast Chris Wallace, Distribution Director, Europe at Genzyme, speaks to Andrea Charles, Editor for Cold Chain IQ, live at IQPC's Nordic Pharmaceutical Supply Chain Forum . Wallace shares his insights on trends in the end-to-end supply chain, the challenges of temperature controlled distribution...
Listen now


The Financial Impact of Serialisation on the Pharmaceutical Industry

Sun, 06/24/2012
Counterfeit and substandard drugs kill over 100,000 people per year and may indirectly cause the death of nearly 1 million patients. In this podcast economist and author Roger Bate and IQ editor Andrea Charles, discuss the cost of counterfeit and substandard medicines to the global economy, where the greatest of counterfeiting threat comes from...
Listen now


Cold Chain Supply: Defining and Implementing a Quality Strategy in Latin America

Thu, 06/14/2012
In this interview Humberto Laserna, Quality Coordinator, Pfizer Peru and Cold Chain IQ Advisor, speaks to Andrea Charles from Cold Chain IQ, about the key challenges of defining and implementing a quality strategy for cold chain supply in Latin America, access and distribution for temperature controlled pharmaceuticals in Peru and the amount of...
Listen now


Ensuring Quality Distribution for Temperature Sensitive Pharmaceuticals in the MENA Region

Thu, 06/07/2012
In this Cold Chain IQ podcast Fadi Badr, Logistic Manager, Mersaco, speaks to Andrea Charles from Cold Chain IQ, about supply chain challenges for raw temperature sensitive materials, preferred means of transportation in the MENA region and technology's impact on the temperature controlled logistics market. Bahr also shares his insights on current...
Listen now


Bayer Healthcare's Carlos Castro on Global Supply Chain Harmonisation – Collaboration with Your Freight Forwarder

Tue, 04/24/2012
With increased global pharmaceutical operations, including significant growth in emerging markets, the need for more intense conversations between partners is becoming ever more crucial. As the pharmaceutical industry seeks to outsource non-core activities it creates a great opportunity for innovative solution providers to go beyond basic freight...
Listen now


64 results
of 3